Primary Site >> Pancreatic Cancer

Gene >> DLL4

Journal: Int J Mol Med. 2006 Apr;17(4):681-5.
Title: Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Author: Katoh, Masuko|Katoh, Masaru
PMID: 16525728
Journal: Clin Cancer Res. 2009 Apr 1;15(7):2291-301.
Title: Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.
Author: Mullendore, Michael E|Koorstra, Jan-Bart|Li, Yue-Ming|Offerhaus, G Johan|Fan, Xing|Henderson, Clark M|Matsui, William|Eberhart, Charles G|Maitra, Anirban|Feldmann, Georg
PMID: 19258443
Journal: Pancreas. 2010 Aug;39(6):897-903.
Title: Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer.
Author: Oishi, Hidekazu|Sunamura, Makoto|Egawa, Shinichi|Motoi, Fuyuhiko|Unno, Michiaki|Furukawa, Toru|Habib, Nagy A|Yagita, Hideo
PMID: 20182391
Journal: Ann Surg Oncol. 2012 Jul;19 Suppl 3:S464-74.
Title: High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Author: Chen, Hai-Tao|Cai, Quan-Cai|Zheng, Jian-Ming|Man, Xiao-Hua|Jiang, Hui|Song, Bin|Jin, Gang|Zhu, Wei|Li, Zhao-Shen
PMID: 21822553
Journal: Clin Cancer Res. 2012 Oct 1;18(19):5374-86.
Title: Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.
Author: Yen, Wan-Ching|Fischer, Marcus M|Hynes, Mark|Wu, Jingjiang|Kim, Edward|Beviglia, Lucia|Yeung, V Pete|Song, Xiaomei|Kapoun, Ann M|Lewicki, John|Gurney, Austin|Simeone, Diane M|Hoey, Timothy
PMID: 22952347
Journal: Cancer Lett. 2013 Mar 1;330(1):11-21.
Title: Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.
Author: Kang, Muxing|Jiang, Biao|Xu, Bin|Lu, Wenjie|Guo, Qingqu|Xie, Qiuping|Zhang, Bo|Dong, Xin|Chen, Daniel|Wu, Yulian
PMID: 23200678
Journal: Pathol Oncol Res. 2015 Sep;21(4):1141-7.
Title: Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.
Author: Zhou, Liangjing|Yu, Leilai|Ding, Guoping|Chen, Wenchao|Zheng, Sixin|Cao, Liping
PMID: 25986715
Journal: Oncotarget. 2016 Jan 19;7(3):3217-32.
Title: Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Author: Ponnurangam, Sivapriya|Dandawate, Prasad R|Dhar, Animesh|Tawfik, Ossama W|Parab, Rajashri R|Mishra, Prabhu Dutt|Ranadive, Prafull|Sharma, Rajiv|Mahajan, Girish|Umar, Shahid|Weir, Scott J|Sugumar, Aravind|Jensen, Roy A|Padhye, Subhash B|Balakrishnan, Arun|
PMID: 26673007
Journal: Oncotarget. 2017 Jan 31;8(5):7740-7752.
Title: Leptin-Notch signaling axis is involved in pancreatic cancer progression.
Author: Harbuzariu, Adriana|Rampoldi, Antonio|Daley-Brown, Danielle S|Candelaria, Pierre|Harmon, Tia L|Lipsey, Crystal C|Beech, Derrick J|Quarshie, Alexander|Ilies, Gabriela Oprea|Gonzalez-Perez, Ruben R
PMID: 27999190
Journal: Exp Ther Med. 2018 Jul;16(1):53-60.
Title: Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma.
Author: Song, Hai-Yan|Wang, Ying|Lan, Hong|Zhang, Yu-Xiang
PMID: 29896227